Blog
-
OthersProteoGenix renews ISO 9001 and ISO 14001 Certifications
Ines Fraccia
4 min read
ProteoGenix is proud to announce the renewal of its ISO 9001:2015 and ISO 14001:2015 Certifications, marking a new milestone in our ongoing commitment to…
Read more
-
Antibody production
How are mouse monoclonal antibodies humanized: current approaches and limitations
Read more -
Antibody production
Addressing Cross-Reactivity in Antibody Research
Read more -
Antibody production
Phage Display vs. Hybridoma: Choosing the Right Method for Monoclonal Antibody Production
Read more -
Antibody production
Harness the Power of Single B Cell Antibody Technologies for Advanced Antibody Development
Read more -
Custom Antibody
Antibody Humanization Techniques
Read more
-
Others
Key events of 2025: Meet us to discuss innovation!
Read more -
Customers success stories
Pioneering the Development of Therapeutic Antibodies for Alzheimer’s Disease
Read more -
Antibody production
The 5 Pillars of Excellence in Stable Cell Line Development
Read more -
Others
ProteoGenix renews ISO 9001 and ISO 14001 Certifications
Read more -
Antibody production
How to generate stable cell lines?
Read more
-
Antibody production
“The COVID-19 pandemic is helping us bridge the divide between virologists and immunologists” – Interview with Dr. Louisa James (QMUL)
Read more -
Antibody production
Reinventing IgY biotherapeutics – interview with Dr. Mara Freire (CICECO, University of Aveiro, Portugal)
Read more -
Antibody production
How the environment shapes immune system development during pregnancy – interview with Dr. Melanie Conrad
Read more -
Antibody production
“Cell-based phage display is helping us isolate more biologically relevant antibodies” – Interview with Dr. Mohamed Alfaleh (King Abdulaziz University)
Read more -
Antibody production
“Researchers are not leveraging the speed and resolution of flow cytometry for clinical evaluation” – Interview with Prof. Tomáš Kalina (Charles University in Prague)
Read more